MD Anderson Cancer Network

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

MD Anderson Cancer Network
Aug 8, 2024, 01:43 | Insight
Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer - MD Anderson Cancer Center 
Approach achieves some of the longest progression-free survival times reported in a clinical trial for…
Jun 16, 2024, 05:49 | Drugs
Vivek Subbiah: Another Tissue-Agnostic FDA approval
Vivek Subbiah shared on LinkedIn:                  . "Yes!…
Jun 15, 2024, 14:10 | Drugs
Vivek Subbiah: FDA granted full traditional approval of RET inhibitor Selpercatinib in RET+ thyroid cancers
Vivek Subbiah shared on LinkedIn:             . "FDA granted full traditional…
May 24, 2024, 00:42 | Societies
Vivek Subbiah wholeheartedly supports and endorses Dr. Giuseppe Curigliano for ESMO President 2027-28
Vivek Subbiah shared on X: "Exciting news! The elections for the ESMO President 2027-2028 are…
Apr 8, 2024, 03:45 | Drugs
Vivek Subbiah: First ADC tissue agnostic drug approved!
Quoting Vivek Subbiah's post on LinkedIn: "Just in time for American Association for Cancer Research…
Mar 16, 2024, 15:39 | Blog
Sarah Sammons: DPYD testing is required before our pharmacy will dispense capecitabine
Sarah Sammons, Breast Medical Oncologist at Dana-Farber’s Breast Oncology Center, shared a post by Vivek Subbiah…
Mar 8, 2024, 15:14 | Blog
Vivek Subbiah: Harnessing the potential of basket trials
Vivek Subbiah recently shared a post on X/Twitter: "Revolutionizing cancer drug development: Harnessing the potential…
All: 7 Posts: 1 - 100
Special Coverage